Ernst Lengyel
Reproducibility track record
1
assessed papers
10/100
mean reproducibility
0
reproduced (C1–C2)
1
flagged
100
total citations
flag rate:
100%
(1/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
Funders
—
Frequent co-authors
Agnieszka Chryplewicz 1Mark A. Eckert 1Allen Zhu 1Rohit Kulkarni 1Decheng Ren 1Dario F. De Jesus 1Chuan He 1Qi Zhang 1Zijie Zhang 1Mengjie Chen 1
Institutions
Howard Hughes Medical Institute 1University of Chicago 1Joslin Diabetes Center 1Harvard University 1
Geography (author institutions)
US 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (595)
Request a reproduction →1 assessed by us (0 reproduced) · 594 not yet assessed — every PubMed paper on record, linked below.
-
Rethinking ovarian cancer III: the past decade and future directions ↗Nature reviews. Cancer · 2026 · PMID 41975230not yet assessed
-
Emerging opportunities for nicotinamide N-methyltransferase (NNMT) inhibitor clinical translation ↗Trends in Pharmacological Sciences · 2026 · PMID 42067476not yet assessed
-
Artificial intelligence predicts survival and identifies pathologic features associated with prognosis in high grade serous ovarian cancer ↗Gynecologic Oncology · 2026not yet assessed
-
FEATMAP pretrained transformation matrices ↗Zenodo (CERN European Organization for Nuclear Research) · 2026not yet assessed
-
FEATMAP pretrained transformation matrices ↗Zenodo (CERN European Organization for Nuclear Research) · 2026not yet assessed
-
Hypomethylation on cfDNA within transposable elements can predict ovarian malignancy in women with adnexal masses ↗medRxiv · 2026not yet assessed
-
not yet assessed
-
Large-scale metabolic profiling of plasma highlights metabolites related to ovarian cancer ↗Gynecologic Oncology · 2026not yet assessed
-
Rethinking ovarian cancer III: the past decade and future directions. ↗Apollo (University of Cambridge) · 2026not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
FEATMAP: Targeted Correction of Acquisition Signatures Harmonizes Medical Foundation Model Embeddings and Enables Robust Task Generalization ↗bioRxiv (Cold Spring Harbor Laboratory) · 2026not yet assessed
-
Radiation-induced amphiregulin drives tumour metastasis ↗Nature · 2025 · PMID 40369065not yet assessed
-
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity ↗Nature · 2025 · PMID 40702186not yet assessed
-
Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10 ↗Cancer Cell · 2025 · PMID 39753138not yet assessed
-
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause ↗Nature Communications · 2025 · PMID 39753552not yet assessed
-
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression ↗Cancer Cell · 2025 · PMID 40578359not yet assessed
-
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial ↗Gynecologic Oncology · 2025 · PMID 39923680not yet assessed
-
LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker ↗npj Precision Oncology · 2025 · PMID 40050409not yet assessed
-
Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth ↗Molecular Cancer Therapeutics · 2025 · PMID 40293279not yet assessed
-
The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes ↗Journal of Ultrasound in Medicine · 2025 · PMID 40586438not yet assessed
-
Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer ↗Cancer Research · 2025 · PMID 40658600not yet assessed
-
O-RADS US Version 2022 Improves Patient Risk Stratification When Compared with O-RADS US Version 2019 ↗Radiology · 2025 · PMID 40100018not yet assessed
-
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types ↗Cancer Research Communications · 2025 · PMID 40981433not yet assessed
-
A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer ↗Clinical Cancer Research · 2025 · PMID 40145935not yet assessed
-
Hybrid artificial intelligence echogenic components‐based diagnosis of adnexal masses on ultrasound ↗Medical Physics · 2025 · PMID 40321943not yet assessed
-
Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer ↗medRxiv · 2025 · PMID 40909841not yet assessed
-
Abstract 1677: Navitoclax, a Bcl-2/xL inhibitor, and YM155, a survivin inhibitor, in combination with carboplatin effectively inhibit ovarian cancer tumor growth ↗Cancer Research · 2025not yet assessed
-
Publisher Correction: Radiation-induced amphiregulin drives tumour metastasis ↗Nature · 2025 · PMID 41214352not yet assessed
-
Abstract 2248: Inhibiting NNMT in cancer-associated fibroblasts reduces immunosuppression ↗Cancer Research · 2025not yet assessed
-
Abstract 2467: Advancing multimodal machine learning techniques to predict platinum resistance in high-grade serous ovarian cancer ↗Cancer Research · 2025not yet assessed
-
Abstract 3757: Development of potent orally bioavailable inhibitors of nicotinamide N-methyl transferase ↗Cancer Research · 2025not yet assessed
-
Abstract 4172: Carnitine metabolism regulates ovarian cancer metastasis ↗Cancer Research · 2025not yet assessed
-
Abstract 1360: Neutrophil extracellular traps establish the pre-metastatic niche in the omentum by expanding innate-like B cells that express IL-10 ↗Cancer Research · 2025not yet assessed
-
Abstract 2449: Using digital pathology to differentiate survival phenotypes in high-grade serous ovarian cancer ↗Cancer Research · 2025not yet assessed
-
Abstract 760: Cell type resolved spatial proteomics defines the transition of precancerous fallopian tube lesions to invasive ovarian cancer ↗Cancer Research · 2025not yet assessed
-
Abstract 762: Spatial transcriptomic characterization of uterine carcinosarcomas identifies MECOM as a tumor regulator ↗Cancer Research · 2025not yet assessed
-
Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score ↗Human Pathology · 2025 · PMID 40389122not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
0920 Stromal NNMT links metabolic and epigenetic drivers of fibrosis in systemic sclerosis ↗Journal of Investigative Dermatology · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Spatial proteomics reveals mechanisms of cell-intrinsic tryptophan metabolism controlling ovarian cancer survival ↗bioRxiv (Cold Spring Harbor Laboratory) · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract B039: Application of unsupervised clustering to whole slide images of high-grade serous ovarian cancer predicts prognosis ↗Cancer Research · 2025not yet assessed
-
Abstract A028: Application of large language models for prognostic prediction in high-grade serous ovarian cancer using unstructured clinical text ↗Cancer Research · 2025not yet assessed
-
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their progression to low-grade serous cancers and identifies novel treatment targets ↗Gynecologic Oncology · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Molecular changes driving low-grade serous ovarian cancer and implications for treatment ↗International Journal of Gynecological Cancer · 2024 · PMID 38950921not yet assessed
-
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness ↗Cell Death and Disease · 2024 · PMID 38806454not yet assessed
-
5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer ↗Gynecologic Oncology · 2024 · PMID 38262243not yet assessed
-
AI-based automated segmentation for ovarian/adnexal masses and their internal components on ultrasound imaging ↗Journal of medical imaging · 2024 · PMID 39114540not yet assessed
-
Systematic treatment and management of postpartum hypertension using remote patient monitoring ↗Pregnancy Hypertension · 2024 · PMID 39709789not yet assessed
-
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer ↗npj Genomic Medicine · 2024 · PMID 39622796not yet assessed
-
Spatial transcriptomics characterizes high-grade serous ovarian cancer and its precursor lesions ↗Gynecologic Oncology · 2024not yet assessed
-
Abstract B068: FOXM1 mediates the crosstalk between tumor microenvironment and ovarian cancer stem cells as revealed by patient-derived organotypic models ↗Cancer Research · 2024not yet assessed
-
Abstract B036: Spatial transcriptomics reveals stepwise biomolecular changes in ovarian cancer tumor microenvironments ↗Cancer Research · 2024not yet assessed
-
Abstract A016: Organotypic high-throughput screening identifies the combinatorial treatment of navitoclax and YM155 that target chemoresistant ovarian cancer cells ↗Cancer Research · 2024not yet assessed
-
Abstract A107: Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer ↗Cancer Research · 2024not yet assessed
-
Abstract B053: Lipid metabolism and lipidomics of ovarian clear cell carcinoma: a comprehensive analysis ↗Cancer Research · 2024not yet assessed
-
Abstract 7047: Comparative analysis of transcriptomic and immunological profiles in treatment-naïve black and non-Hispanic White women with high-grade serous ovarian cancer ↗Cancer Research · 2024not yet assessed
-
not yet assessed
-
EP23.23: Diagnosis of adnexal lesions using ultrasound‐based artificial intelligence ↗Ultrasound in Obstetrics and Gynecology · 2024 · PMID 39249370not yet assessed
-
Metformin for Patients with Advanced Stage Ovarian Cancer: A Randomized Phase Ii Placebo-Controlled Trial ↗SSRN Electronic Journal · 2024not yet assessed
-
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2024not yet assessed
-
Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis ↗Nature Metabolism · 2023 · PMID 37653041not yet assessed
-
Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis ↗JCI Insight · 2023 · PMID 36795484not yet assessed
-
The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells ↗Journal of Extracellular Vesicles · 2023 · PMID 36973758not yet assessed
-
Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort ↗JAMA Network Open · 2023 · PMID 37440228not yet assessed
-
Understanding Long-Term Survival of Patients with Ovarian Cancer—The Tumor Microenvironment Comes to the Forefront ↗Cancer Research · 2023 · PMID 37128849not yet assessed
-
Normal saline remodels the omentum and stimulates its receptivity for transcoelomic metastasis ↗JCI Insight · 2023 · PMID 37345662not yet assessed
-
A Comparison of Obstetric Interventions and Outcomes Between Black and White Patients at an Urban Tertiary Medical Center ↗Reproductive Sciences · 2023 · PMID 36717463not yet assessed
-
Decoding evolutionary trajectories of ovarian cancer metastasis ↗Cancer Cell · 2023 · PMID 37311411not yet assessed
-
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression ↗medRxiv · 2023 · PMID 38014221not yet assessed
-
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness ↗bioRxiv (Cold Spring Harbor Laboratory) · 2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Data from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer ↗2023not yet assessed
-
not yet assessed
-
Data from The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer ↗2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Data from Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer ↗2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract 3655: Exploring the role of FasL in the ovarian cancer tumor microenvironment ↗Cancer Research · 2023not yet assessed
-
Abstract 4462: Immunoregulatory effects of NNMT-expressing cancer-associated fibroblasts ↗Cancer Research · 2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract 6068: Methylomic, transcriptomic and immune profiles of high grade serous ovarian cancer among Black and non-Hispanic White women ↗Cancer Research · 2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract 6782: Spatial transcriptomics of serous tubal intraepithelial carcinoma and its putative precursor lesions ↗Cancer Research · 2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
In Patients with BRCA-negative and HRD-negative Epithelial Ovarian Cancer, Should Molecular Profiling be Routinely Done to Guide Adjuvant Therapy? ↗Cambridge University Press eBooks · 2023not yet assessed
-
High-depth multi-omics analysis defines the transition of borderline, micropapillary and low-grade serous cancers (2310) ↗Gynecologic Oncology · 2023not yet assessed
-
A Cellular atlas of the human fallopian tube reveals the metamorphosis of secretory epithelial cells during the menstrual cycle and menopause ↗medRxiv · 2023 · PMID 38045369not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Data from Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer ↗2023not yet assessed
-
Deep Visual Proteomics defines single-cell identity and heterogeneity ↗Nature Biotechnology · 2022 · PMID 35590073not yet assessed
-
The adipocyte microenvironment and cancer ↗Cancer and Metastasis Reviews · 2022 · PMID 35941408not yet assessed
-
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing ↗Cell Reports · 2022 · PMID 36543131not yet assessed
-
Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer ↗JCO Oncology Practice · 2022 · PMID 35201895not yet assessed
-
Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment ↗Cancers · 2022 · PMID 36139624not yet assessed
-
Ovarian Masses: The Value of Acoustic Shadowing on Ultrasound Examination ↗Journal of Ultrasound in Medicine · 2022 · PMID 36114807not yet assessed
-
High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas ↗Gynecologic Oncology Reports · 2022 · PMID 35519002not yet assessed
-
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing ↗bioRxiv (Cold Spring Harbor Laboratory) · 2022not yet assessed
-
Adipocytes reprogram glucose metabolism in cancer cells promoting metastasis ↗bioRxiv (Cold Spring Harbor Laboratory) · 2022not yet assessed
-
Sarcoma regimens for gynecologic carcinosarcoma: Is there a benefit? (186) ↗Gynecologic Oncology · 2022not yet assessed
-
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis ↗Cell · 2021 · PMID 33964209not yet assessed
-
Change in Health-Related Socioeconomic Risk Factors and Mental Health During the Early Phase of the COVID-19 Pandemic: A National Survey of U.S. Women ↗Journal of Women s Health · 2021 · PMID 33818123not yet assessed
-
Resilience: a mediator of the negative effects of pandemic-related stress on women’s mental health in the USA ↗Archives of Women s Mental Health · 2021not yet assessed
-
The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis ↗Cancers · 2021 · PMID 34439084not yet assessed
-
The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer ↗Cancer Research · 2021 · PMID 34224372not yet assessed
-
The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment ↗Cancers · 2021 · PMID 34201616not yet assessed
-
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas ↗Gynecologic Oncology · 2021 · PMID 34452747not yet assessed
-
Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas ↗Gynecologic Oncology · 2021not yet assessed
-
The balance between toxic versus nontoxic microRNAs determines platinum sensitivity in ovarian cancer ↗bioRxiv (Cold Spring Harbor Laboratory) · 2021not yet assessed
-
Neoadjuvant treatment as a window to chemotherapy driven alterations to the genome and transcriptome of high-grade serous ovarian cancer ↗Gynecologic Oncology · 2021not yet assessed
-
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer ↗Cancer Research · 2021 · PMID 34737212not yet assessed
-
Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment ↗Obstetrics and Gynecology · 2020 · PMID 33278287not yet assessed
-
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance ↗Cancer Research · 2020 · PMID 32054768not yet assessed
-
A streamlined mass spectrometry–based proteomics workflow for large‐scale FFPE tissue analysis ↗The Journal of Pathology · 2020 · PMID 32154592not yet assessed
-
Deconstructing tumor heterogeneity: the stromal perspective ↗Oncotarget · 2020 · PMID 33088423not yet assessed
-
Are We Ready for Hyperthermic Intraperitoneal Chemotherapy in the Upfront Treatment of Ovarian Cancer? ↗JAMA Network Open · 2020 · PMID 32840618not yet assessed
-
Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1–Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti–PD-1 Monoclonal Antibody Therapy ↗JCO Precision Oncology · 2020 · PMID 33215053not yet assessed
-
not yet assessed
-
Healthy food for trainees: a call to action ↗Postgraduate Medical Journal · 2020 · PMID 32820089not yet assessed
-
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts ↗Nature · 2019 · PMID 31043742not yet assessed
-
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake ↗Communications Biology · 2019 · PMID 31646189not yet assessed
-
RADAR: differential analysis of MeRIP-seq data with a random effect model⚑Genome biology · 2019 · PMID 31870409L1 10/100 ⚑
-
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer ↗Molecular Cancer Research · 2019 · PMID 30655321not yet assessed
-
New Roles for Glycogen in Tumor Progression ↗Trends in cancer · 2019 · PMID 31311654not yet assessed
-
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference ↗Cancer · 2019 · PMID 30835824not yet assessed
-
Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk ↗Cell Reports · 2019 · PMID 31851935not yet assessed
-
Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis ↗Gynecologic Oncology · 2019 · PMID 30797592not yet assessed
-
Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis ↗Molecular Cancer Therapeutics · 2019 · PMID 31562255not yet assessed
-
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6 ↗Scientific Reports · 2019 · PMID 30914657not yet assessed
-
Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation ↗Proceedings of the National Academy of Sciences · 2019 · PMID 31591248not yet assessed
-
Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report ↗International Journal of Gynecological Pathology · 2019 · PMID 30807370not yet assessed
-
Profiling the metabolomic composition of the ovarian cancer secretome and ovarian cancer-induced metabolomic changes in mesothelial cells ↗Gynecologic Oncology · 2019not yet assessed
-
Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis ↗The FASEB Journal · 2019not yet assessed
-
A streamlined mass spectrometry-based proteomics workflow for large scale FFPE tissue analysis ↗bioRxiv (Cold Spring Harbor Laboratory) · 2019not yet assessed
-
RADAR: Differential analysis of MeRIP-seq data with a random effect model ↗bioRxiv (Cold Spring Harbor Laboratory) · 2019not yet assessed
-
Early postoperative increases in platelet count is associated with trend towards improved survival in high grade serous ovarian cancer ↗Gynecologic Oncology · 2019not yet assessed
-
Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS ↗Clinical Cancer Research · 2019not yet assessed
-
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer ↗Nature Cell Biology · 2018 · PMID 30154548not yet assessed
-
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis ↗Oncogene · 2018 · PMID 29398710not yet assessed
-
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum ↗The Journal of Experimental Medicine · 2018 · PMID 30567719not yet assessed
-
Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors ↗Trends in cancer · 2018 · PMID 29709261not yet assessed
-
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis ↗Cell Metabolism · 2018 · PMID 30174305not yet assessed
-
Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer ↗Cell · 2018 · PMID 30241606not yet assessed
-
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor–Engineered T Cells for Ovarian Cancer ↗Clinical Cancer Research · 2018 · PMID 29720506not yet assessed
-
A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns ↗Biomaterials · 2018 · PMID 30396040not yet assessed
-
The Tumor Microenvironment Takes Center Stage in Ovarian Cancer Metastasis ↗Trends in cancer · 2018 · PMID 30064659not yet assessed
-
The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer ↗Gynecologic Oncology · 2018 · PMID 30471899not yet assessed
-
Abstract A15: Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis ↗Clinical Cancer Research · 2018not yet assessed
-
Nicotinamide N-methyltransferase metabolically reprograms the stroma to promote ovarian cancer metastasis.Max Planck Digital Library · 2018not yet assessed
-
Diverse indications for risk-reducing salpingo-oophorectomy: Experience from a tertiary care center ↗Gynecologic Oncology · 2018not yet assessed
-
Polycomb fusion proteins in endometrial stromal sarcomas ↗Gynecologic Oncology · 2018not yet assessed
-
Abstract IA06: Stromal regulation of metastasis ↗Clinical Cancer Research · 2018not yet assessed
-
Abstract A28: Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment ↗Clinical Cancer Research · 2018not yet assessed
-
Abstract 5474: Activity of the S1P pathway promotes ovarian cancer and serves as a novel metabolic target of metformin ↗Cancer Research · 2018not yet assessed
-
Effective screening of neoantigen-specific cytotoxic t cells. ↗Journal of Clinical Oncology · 2018not yet assessed
-
Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis.Max Planck Digital Library · 2018not yet assessed
-
Proteomics identifies CT45 as a mediator of chemosensitivity and immunotherapy target in ovarian cancer.Max Planck Digital Library · 2018not yet assessed
-
Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment.Max Planck Digital Library · 2018not yet assessed
-
Who are the long-term survivors of high grade serous ovarian cancer? ↗Gynecologic Oncology · 2017 · PMID 29128106not yet assessed
-
High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer ↗Gynecologic Oncology · 2017 · PMID 28456378not yet assessed
-
Unsaturated Fatty Acids Maintain Cancer Cell Stemness ↗Cell stem cell · 2017 · PMID 28257705not yet assessed
-
An activity-dependent proximity ligation platform for spatially resolved quantification of active enzymes in single cells ↗Nature Communications · 2017 · PMID 29176560not yet assessed
-
A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth ↗SLAS DISCOVERY · 2017 · PMID 28346091not yet assessed
-
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention ↗Cancer Prevention Research · 2017 · PMID 28264838not yet assessed
-
Prolactin Receptor–Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity ↗Cancer Research · 2017 · PMID 28202518not yet assessed
-
Abstract 3062: Metformin inhibits TGFβ-induced stromal ECM remodeling to impede invasion in ovarian cancer ↗Cancer Research · 2017not yet assessed
-
Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION ↗Clinical Cancer Research · 2017not yet assessed
-
Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts ↗Cancer Research · 2017not yet assessed
-
Methods of treating cancers with CT45 targeted therapies ↗University of Chicago · 2017not yet assessed
-
Methods of treating cancers with CT45 targeted therapies ↗University of Chicago · 2017not yet assessed
-
METHODS OF TREATING CANCERS WITH CT45 TARGETED THERAPIES ↗University of Chicago · 2017not yet assessed
-
METHODS OF TREATING CANCERS WITH CT45 TARGETED THERAPIES ↗University of Chicago · 2017not yet assessed
-
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers ↗Cell Metabolism · 2016 · PMID 27746051not yet assessed
-
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells ↗Molecular Cancer Research · 2016 · PMID 27758876not yet assessed
-
Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status ↗Nature Communications · 2016 · PMID 27561551not yet assessed
-
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube ↗Cancer Discovery · 2016 · PMID 27856443not yet assessed
-
Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform ↗Molecular Cancer Therapeutics · 2016 · PMID 27466355not yet assessed
-
A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies ↗Gynecologic Oncology · 2016 · PMID 27103176not yet assessed
-
Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy ↗Nature Communications · 2016not yet assessed
-
Abstract A68: Sphingosine kinase 1 as a mediator and predictor of metformin's protective effect in ovarian cancer. ↗Clinical Cancer Research · 2016not yet assessed
-
Ovarian cancer patients treated with intraperitoneal/intravenous chemotherapy do not experience increased toxicity at recurrence ↗Gynecologic Oncology · 2016not yet assessed
-
Predictors of Early Recurrence in Advanced Stage, Optimally Debulked Ovarian Cancers ↗Gynecologic Oncology · 2016not yet assessed
-
Abstract B39: Identification and targeting mediators of chemoresistance using the patient-derived xenograft model of ovarian cancer ↗Clinical Cancer Research · 2016not yet assessed
-
Whole–genome characterization of chemoresistant ovarian cancer ↗Nature · 2015 · PMID 26017449not yet assessed
-
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer ↗Nature reviews. Cancer · 2015 · PMID 26493647not yet assessed
-
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment ↗Oncogene · 2015 · PMID 25867073not yet assessed
-
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy ↗Nature Communications · 2015 · PMID 25653139not yet assessed
-
Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment ↗Clinical Cancer Research · 2015 · PMID 25691772not yet assessed
-
The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma ↗Oncotarget · 2015 · PMID 25839163not yet assessed
-
Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma ↗Gynecologic Oncology · 2015 · PMID 26115975not yet assessed
-
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis ↗Oncogene · 2015 · PMID 25798837not yet assessed
-
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer ↗Oncotarget · 2015 · PMID 26172303not yet assessed
-
Patterns and utility of routine surveillance in high grade endometrial cancer ↗Gynecologic Oncology · 2015 · PMID 25838164not yet assessed
-
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity ↗Journal of Visualized Experiments · 2015 · PMID 26780294not yet assessed
-
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity ↗Journal of Visualized Experiments · 2015not yet assessed
-
Advancing metformin as a metabolic therapeutic for ovarian cancer: Testing in non-diabetic patient-derived xenograft avatars ↗Gynecologic Oncology · 2015not yet assessed
-
Erratum: Corrigendum: Whole–genome characterization of chemoresistant ovarian cancer ↗Nature · 2015 · PMID 26503049not yet assessed
-
Abstract AS23: Microenvironment mediated downregulation of miR-193b promotes ovarian cancer metastasis ↗Clinical Cancer Research · 2015not yet assessed
-
Abstract 4416: Reversal of chemoresistance in ovarian cancer cells by the liposomal co-delivery of MDR inhibitors and paclitaxel ↗Cancer Research · 2015not yet assessed
-
Reversal of Chemoresistance in Ovarian Cancer by Co‐Delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform ↗The FASEB Journal · 2015not yet assessed
-
A prospective study to evaluate diffusion weighted MRI imaging in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies ↗Gynecologic Oncology · 2015not yet assessed
-
Focused Plenary I - Pre-Clinical Discovery2015 Annual Meeting on Women's Cancer® · 2015not yet assessed
-
Old Drug, New Trick ↗Obstetrical & Gynecological Survey · 2015not yet assessed
-
Abstract POSTER-TECH-1123: Advancing metformin as therapeutic for ovarian cancer: metabolomic profiling of mouse ovarian tumors identifies metformin-induced global metabolic changes ↗Clinical Cancer Research · 2015not yet assessed
-
Abstract POSTER-CTRL-1217: Human placental lactogen-functionalized bimodal imaging probe for human ovarian cancer detection ↗Clinical Cancer Research · 2015not yet assessed
-
Abstract POSTER-BIOL-1305: Lovastatin decreases macrophage IL-6 and CXCL1 production in an ovarian tam-like model reducing ovarian cancer cell invasion ↗Clinical Cancer Research · 2015not yet assessed
-
Abstract POSTER-THER-1440: Targeted delivery of doxorubicin loaded nanobins to ovarian cancer cells through the urokinase plasminogen activator system ↗Clinical Cancer Research · 2015not yet assessed
-
Subsequent chemotherapy is well tolerated in patients who underwent primary adjuvant intraperitoneal chemotherapy for ovarian, fallopian and primary peritoneal cancers ↗Gynecologic Oncology · 2015not yet assessed
-
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasisPMC · 2015not yet assessed
-
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion ↗Journal of Clinical Investigation · 2014 · PMID 25202979not yet assessed
-
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models ↗American Journal of Obstetrics and Gynecology · 2014 · PMID 25446664not yet assessed
-
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer ↗Oncogene · 2014 · PMID 25174399not yet assessed
-
Old drug, new trick: Repurposing metformin for gynecologic cancers? ↗Gynecologic Oncology · 2014 · PMID 25455733not yet assessed
-
Statin Therapy Is Associated with Improved Survival in Patients with Non-Serous-Papillary Epithelial Ovarian Cancer: A Retrospective Cohort Analysis ↗PLoS ONE · 2014 · PMID 25118694not yet assessed
-
Three-dimensional modeling of ovarian cancer ↗Advanced Drug Delivery Reviews · 2014 · PMID 25034878not yet assessed
-
Epithelial Ovarian Cancer Experimental ModelsPMC · 2014not yet assessed
-
MicroRNA 206 is associated with longer overall survival and platinum sensitivity in serous epithelial ovarian cancer ↗Gynecologic Oncology · 2014not yet assessed
-
Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins ↗University of Chicago · 2014not yet assessed
-
Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins ↗University of Chicago · 2014not yet assessed
-
Adipose tissue and adipocytes support tumorigenesis and metastasis ↗Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2013 · PMID 23500888not yet assessed
-
Epithelial ovarian cancer experimental models ↗Oncogene · 2013 · PMID 23934194not yet assessed
-
miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression ↗American Journal Of Pathology · 2013 · PMID 23499550not yet assessed
-
Expression of the Homeobox Gene HOXA9 in Ovarian Cancer Induces Peritoneal Macrophages to Acquire an M2 Tumor-Promoting Phenotype ↗American Journal Of Pathology · 2013 · PMID 24332016not yet assessed
-
Urokinase Plasminogen Activator System–Targeted Delivery of Nanobins as a Novel Ovarian Cancer Therapy ↗Molecular Cancer Therapeutics · 2013 · PMID 24061648not yet assessed
-
Abstract PR11: Ovarian cancer cells activate the mesothelium in the peritoneal microenvironment promoting fibronectin production and the early steps of metastasis ↗Clinical Cancer Research · 2013not yet assessed
-
Abstract 2611: The developmental patterning gene HOXA9 promotes ovarian cancer growth via paracrine effects on mesenchymal stem cells and peritoneal fibroblasts. ↗Cancer Research · 2013not yet assessed
-
Abstract B32: The role of the glucocorticoid receptor (GR) in inhibiting chemotherapy-induced apoptosis in high-grade serous ovarian carcinoma (HGS-OvCa) ↗Clinical Cancer Research · 2013not yet assessed
-
Identifying the microrna expression signature associated with chemoresistance in ovarian cancer ↗Gynecologic Oncology · 2013not yet assessed
-
Abstract IA30: Metabolic symbiosis: The contribution of adipocytes to visceral metastasis ↗Cancer Research · 2013not yet assessed
-
Regulation of ovarian cancer metastatic colonization by MIR-193B ↗Gynecologic Oncology · 2013not yet assessed
-
A prospective study to evaluate diffusion weighted MRI (DW-MRI) imaging in the detection of peritoneal carcinomatosis ↗Gynecologic Oncology · 2013not yet assessed
-
Abstract 1870: Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity. ↗Cancer Research · 2013not yet assessed
-
Summary of the 2013 American Association for Cancer Research (AACR) Annual Meeting ↗Gynecologic Oncology · 2013 · PMID 23926600not yet assessed
-
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer ↗Cancer Discovery · 2012 · PMID 23171795not yet assessed
-
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts ↗Journal of Clinical Investigation · 2012 · PMID 22945634not yet assessed
-
Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure ↗Gynecologic Oncology · 2012 · PMID 22835717not yet assessed
-
Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma ↗Gynecologic Oncology · 2012 · PMID 23237768not yet assessed
-
Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity ↗Obstetrical & Gynecological Survey · 2012not yet assessed
-
Correction: Corrigendum: CD95 promotes tumour growth ↗Nature · 2012not yet assessed
-
Abstract 1481: microRNA mediated reprograming of fibroblasts into cancer associated fibroblasts in ovarian cancer ↗Cancer Research · 2012not yet assessed
-
Abstract 48: Activation of c-Met receptor signaling by carcinoma-associated fibroblasts in the tumor microenvironment ↗Cancer Research · 2012not yet assessed
-
Abstract 5185: Ovarian cancer cells induce fibronectin production in the peritoneal microenvironment through a TGFβRI-dependent mechanism which promotes the early steps of metastasis ↗Cancer Research · 2012not yet assessed
-
Utility of routine surveillance methods in detecting recurrence in high grade endometrial cancer patients ↗Gynecologic Oncology · 2012not yet assessed
-
Metformin: A novel agent for ovarian cancer prevention and adjuvant treatment ↗Gynecologic Oncology · 2012not yet assessed
-
Abstract 2885: Urokinase plasminogen activator system targeted delivery of arsenic trioxide loaded nanobins as a novel ovarian cancer therapeutic ↗Cancer Research · 2012not yet assessed
-
Utility of routine surveillance methods in detecting recurrence in high grade endometrial cancer patients ↗Gynecologic Oncology · 2012not yet assessed
-
Methods for treating ovarian cancer by inhibiting fatty acid binding proteins ↗University of Chicago · 2012not yet assessed
-
Methods for treating ovarian cancer by inhibiting fatty acid binding proteins ↗University of Chicago · 2012not yet assessed
-
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth ↗Nature Medicine · 2011 · PMID 22037646not yet assessed
-
Rethinking ovarian cancer: recommendations for improving outcomes ↗Nature reviews. Cancer · 2011 · PMID 21941283not yet assessed
-
Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity ↗Obstetrics and Gynecology · 2011 · PMID 22183212not yet assessed
-
A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer ↗Gynecologic Oncology · 2011 · PMID 21276608not yet assessed
-
Let‐7 modulates acquired resistance of ovarian cancer to Taxanes via IMP‐1‐mediated stabilization of multidrug resistance 1 ↗International Journal of Cancer · 2011 · PMID 21618519not yet assessed
-
Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis ↗Clinical Cancer Research · 2011 · PMID 21551255not yet assessed
-
The First Line of Intra-abdominal Metastatic Attack: Breaching the Mesothelial Cell Layer ↗Cancer Discovery · 2011 · PMID 22013555not yet assessed
-
FOXL2 and SOX9 Distinguish the Lineage of the Sex Cord–Stromal Cells in Gonadoblastomas ↗Pediatric and Developmental Pathology · 2011 · PMID 21682576not yet assessed
-
The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis ↗Gynecologic Oncology · 2011 · PMID 21996264not yet assessed
-
Acute inflammatory reaction following placement of sodium hyaluronate-carboxymethylcellulose barrier in a young woman undergoing gynecologic surgery: a case report. ↗PubMed · 2011 · PMID 21366131not yet assessed
-
Erratum: CD95 promotes tumour growth ↗Nature · 2011not yet assessed
-
Modulation of lipid metabolism in interacting visceral adipocytes and ovarian cancer cells ↗The FASEB Journal · 2011not yet assessed
-
Locoregional Failure In High-risk Endometrial Cancer And The Role Of Whole Pelvis External Beam RT ↗International Journal of Radiation Oncology*Biology*Physics · 2011not yet assessed
-
Abstract 1544: Identification of microRNA which regulates peritoneal dissemination of ovarian cancer ↗Cancer Research · 2011not yet assessed
-
Erratum: CD95 promotes tumour growth ↗Nature · 2011not yet assessed
-
Metformin Inhibits Growth and Invasion of Ovarian cancer; An Effect That Maybe Mediated By AMP-Activated Kinase대한산부인과학회 학술발표논문집 · 2011not yet assessed
-
Ovarian Cancer Development and Metastasis ↗American Journal Of Pathology · 2010 · PMID 20651229not yet assessed
-
CD95 promotes tumour growth ↗Nature · 2010 · PMID 20505730not yet assessed
-
Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis ↗Oncogene · 2010 · PMID 21119598not yet assessed
-
Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis ↗Clinical Cancer Research · 2010 · PMID 21149615not yet assessed
-
An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Reduces Tumor Burden and Metastasis in a Preclinical Model of Ovarian Cancer Metastasis ↗Neoplasia · 2010 · PMID 20072648not yet assessed
-
The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma ↗Gynecologic Oncology · 2010 · PMID 21168200not yet assessed
-
Abstract LB-341: CD95/FAS promotes tumorigenesis ↗Cancer Research · 2010not yet assessed
-
Abstract 2331: One of the first steps of metastasis is remodeling of the extracellular matrix microenvironment ↗Cancer Research · 2010not yet assessed
-
Abstract A103: The effect of 17β-estradiol on ovarian carcinogenesis in vitro and in a genetic mouse model ↗Cancer Prevention Research · 2010not yet assessed
-
MMP-2 functions as an early response protein in ovarian cancer metastasis ↗Cell Cycle · 2009 · PMID 19221481not yet assessed
-
Organotypic Models of Metastasis: A Three-dimensional Culture Mimicking the Human Peritoneum and Omentum for the Study of the Early Steps of Ovarian Cancer Metastasis ↗Cancer treatment and research · 2009 · PMID 19763444not yet assessed
-
β3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer ↗American Journal Of Pathology · 2009 · PMID 19808644not yet assessed
-
The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer ↗Fertility and Sterility · 2009 · PMID 19643405not yet assessed
-
The Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial–stromal interactions ↗Molecular and Cellular Endocrinology · 2009 · PMID 20036708not yet assessed
-
Up-Regulation of α5-Integrin by E-Cadherin Loss in Hypoxia and Its Key Role in the Migration of Extravillous Trophoblast Cells during Early Implantation ↗Endocrinology · 2009 · PMID 19497979not yet assessed
-
Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation ↗Human Molecular Genetics · 2009 · PMID 19584084not yet assessed
-
Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice ↗Cancer Prevention Research · 2009 · PMID 19737983not yet assessed
-
Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice ↗Obstetrical & Gynecological Survey · 2009not yet assessed
-
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressorsPubMed Central · 2009not yet assessed
-
Phase II study comparing volociximab (an antiangiogenic antibody) and pegylated liposomal doxorubicin (PLD) with PLD alone in recurrent ovarian or primary peritoneal cancer ↗Journal of Clinical Oncology · 2009not yet assessed
-
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin ↗Journal of Clinical Investigation · 2008 · PMID 18340378not yet assessed
-
Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target ↗Cancer Research · 2008 · PMID 18381440not yet assessed
-
Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer ↗Gynecologic Oncology · 2008 · PMID 18823649not yet assessed
-
A Novel Multipurpose Monoclonal Antibody for Evaluating Human c-Met Expression in Preclinical and Clinical Settings ↗Applied immunohistochemistry & molecular morphology · 2008 · PMID 18815565not yet assessed
-
Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer ↗Gynecologic Oncology · 2008 · PMID 18554701not yet assessed
-
519 POSTER A phase 2, single-arm study of volociximab (an anti-a5b1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer ↗European Journal of Cancer Supplements · 2008not yet assessed
-
Transverse Transperineal Repair of a Pessary-induced Mid-rectovaginal Fistula ↗Journal of Pelvic Medicine and Surgery · 2008not yet assessed
-
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 ↗Genes & Development · 2008 · PMID 18381893not yet assessed
-
Ovarian cancer treatment in black and white women: A comparison of clinico-pathologic factors and outcome ↗Journal of Clinical Oncology · 2008not yet assessed
-
A Special Key for Unlocking the Door to Targeted Therapies of Breast Cancer ↗The Scientific World JOURNAL · 2008 · PMID 18836657not yet assessed
-
Let-7 expression defines two differentiation stages of cancer ↗Proceedings of the National Academy of Sciences · 2007 · PMID 17600087not yet assessed
-
c-Met Overexpression Is a Prognostic Factor in Ovarian Cancer and an Effective Target for Inhibition of Peritoneal Dissemination and Invasion ↗Cancer Research · 2007 · PMID 17308108not yet assessed
-
Let-7 Prevents Early Cancer Progression by Suppressing Expression of the Embryonic Gene HMGA2 ↗Cell Cycle · 2007 · PMID 17957144not yet assessed
-
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra‐cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum ↗International Journal of Cancer · 2007 · PMID 17546601not yet assessed
-
Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and β1-Integrin on the Cell Surface ↗Journal of Biological Chemistry · 2007 · PMID 18048360not yet assessed
-
Tyrosine Kinase Mutations in Human Cancer ↗Current Molecular Medicine · 2007 · PMID 17311534not yet assessed
-
Differential expression of c‐Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue ↗Histopathology · 2007 · PMID 17593080not yet assessed
-
Src Induces Urokinase Receptor Gene Expression and Invasion/Intravasation via Activator Protein-1/p-c-Jun in Colorectal Cancer ↗Molecular Cancer Research · 2007 · PMID 17510314not yet assessed
-
Treatment with an uPAR (ATN 658) antibody inhibits ovarian cancer metastasis.Molecular Cancer Therapeutics · 2007not yet assessed
-
Β3-Integrin expression reduces ovarian cancer proliferation and metastasisMolecular Cancer Therapeutics · 2007not yet assessed
-
The evaluation of norethindrone, ethinyl estradiol and a GnRh agonist as chemoprevention of ovarian cancer using a newly developed genetically engineered mouse model of ovarian cancer.Cancer Epidemiology and Prevention Biomarkers · 2007not yet assessed
-
not yet assessed
-
Receptor-mediated delivery: compositions and methods ↗University of Chicago · 2007not yet assessed
-
Receptor-mediated delivery: compositions and methods ↗University of Chicago · 2007not yet assessed
-
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy ↗International Journal of Radiation Oncology*Biology*Physics · 2006 · PMID 16757127not yet assessed
-
PDGFR-α as a potential therapeutic target in uterine sarcomas ↗Gynecologic Oncology · 2006 · PMID 17049587not yet assessed
-
Transcriptional Control of Proteases ↗Kluwer Academic Publishers eBooks · 2006not yet assessed
-
Development of an organotypic peritoneal 3D culture to study peritoneal attachment of ovarian cancer cells.Cancer Research · 2006not yet assessed
-
P4. Tumor suppressor Pdcd4 inhibits invasion and regulates urokinase-receptor (u-PAR) gene expression via Sp-transcription factors ↗European Journal of Cancer Supplements · 2006not yet assessed
-
P3. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2α-related factor binding to different regions of the urokinase receptor (u-PAR) gene in resected colorectal cancers ↗European Journal of Cancer Supplements · 2006not yet assessed
-
Combination Analysis of Activator Protein-1 Family Members, Sp1 and an Activator Protein-2α-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers ↗Clinical Cancer Research · 2005 · PMID 16361535not yet assessed
-
C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu ↗International Journal of Cancer · 2004 · PMID 15455388not yet assessed
-
Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation ↗Oncogene · 2004 · PMID 15516977not yet assessed
-
Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia ↗Gynecologic Oncology · 2004 · PMID 15262143not yet assessed
-
Isolation and characterization of Rac1 pseudogenes (ψ1Rac1–ψ4Rac1) in the human genome ↗Gene · 2004 · PMID 15474301not yet assessed
-
not yet assessed
-
Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers. ↗PubMed · 2003 · PMID 12796395not yet assessed
-
C-Met overexpression identifies breast cancer patients with poor clinical outcome independent of Her2/neumediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) · 2003not yet assessed
-
RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene ↗Humana Press eBooks · 2003 · PMID 21340784not yet assessed
-
Erster Hinweis auf eine Rolle des neu beschriebenenen Tumor-Suppressorgens Pdcd4 als Regulator des Invasionsmoleküls Urokinase Rezeptor ↗Langenbecks Archiv für Chirurgie. Supplement · 2003not yet assessed
-
not yet assessed
-
Role of β3-endonexin in the regulation of NF-κB-dependent expression of urokinase-type plasminogen activator receptor ↗Journal of Cell Science · 2002 · PMID 12244126not yet assessed
-
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. ↗PubMed · 2001 · PMID 11489818not yet assessed
-
Expression of Latent Matrix Metalloproteinase 9 (MMP-9) Predicts Survival in Advanced Ovarian Cancer ↗Gynecologic Oncology · 2001 · PMID 11531282not yet assessed
-
Integrin αvβ3/Vitronectin Interaction Affects Expression of the Urokinase System in Human Ovarian Cancer Cells ↗Journal of Biological Chemistry · 2001 · PMID 11331280not yet assessed
-
β3A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through aPEA3/ets Transcriptional Silencing Element in the u-PAR Promoter ↗Molecular and Cellular Biology · 2001 · PMID 11238946not yet assessed
-
Gastrin Induces Expression and Promoter Activity of the Vesicular Monoamine Transporter Subtype 2 ↗Endocrinology · 2001 · PMID 11459816not yet assessed
-
Physiology of cervical ripening and dilatation ↗Der Gynäkologe · 2001not yet assessed
-
First clinical evidence of a combined AP-2/Sp1 promoter motif as a tumor-specific activator of urokinase-receptor (u-PAR) expression in resected gastrointestinal cancers ↗European Journal of Cancer · 2001not yet assessed
-
Ras Regulation of urokinase-type plasminogen activator ↗Methods in enzymology on CD-ROM/Methods in enzymology · 2001 · PMID 11400328not yet assessed
-
JNK and p38MAPK are activated during graft reperfusion and not during cold storage in rat liver transplantation ↗Transplantation Proceedings · 2001 · PMID 11267133not yet assessed
-
Survival of Ewing's sarcoma patients in Hungary ↗European Journal of Cancer · 2001not yet assessed
-
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b ↗Oncogene · 2000 · PMID 10871853not yet assessed
-
The urokinase plasminogen activator system as a novel target for tumour therapy ↗Fibrinolysis and Proteolysis · 2000not yet assessed
-
Downregulation of a Mitogen-Activated Protein Kinase Signaling Pathway in the Placentas of Women With Preeclampsia ↗Obstetrics and Gynecology · 2000not yet assessed
-
not yet assessed
-
Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor ↗Journal of Biological Chemistry · 1999 · PMID 10347197not yet assessed
-
UVB Increases Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression1 ↗Journal of Investigative Dermatology · 1999 · PMID 10417621not yet assessed
-
[The clinical importance of keratin 18 in breast cancer]. ↗PubMed · 1999 · PMID 10209854not yet assessed
-
In vitro modulation of human melanoma cell invasion and proliferation by all-frans-retinoic acid ↗Melanoma Research · 1998 · PMID 9664142not yet assessed
-
UVB induces the transcription of urokinase receptor in A431 cells ↗Journal of Dermatological Science · 1998not yet assessed
-
Molecular cloning, expression and promoter analysis of the vesicular monoamine transporter subtype 2 (VMAT2) in human and rat gastric enterochromaffin-like (ECL) cells ↗Gastroenterology · 1998not yet assessed
-
[Juvenile aneuploid papillary cancer of the thyroid with pulmonary metastasis]. ↗PubMed · 1998 · PMID 9555165not yet assessed
-
Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades ↗Oncogene · 1997 · PMID 9136992not yet assessed
-
Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade ↗Oncogene · 1997 · PMID 9191056not yet assessed
-
Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences ↗Journal of Biological Chemistry · 1996 · PMID 8631874not yet assessed
-
Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. ↗PubMed · 1996 · PMID 9816144not yet assessed
-
Requirement of an Upstream AP-1 Motif for the Constitutive and Phorbol Ester-inducible Expression of the Urokinase-type Plasminogen Activator Receptor Gene ↗Journal of Biological Chemistry · 1996 · PMID 8798512not yet assessed
-
Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line ↗Journal of Cellular Biochemistry · 1996 · PMID 8761947not yet assessed
-
Cytological diagnosis of zosteriform skin metastases in undiagnosed breast carcinoma ↗British Journal of Dermatology · 1996 · PMID 8949466not yet assessed
-
Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. ↗PubMed · 1995 · PMID 7850814not yet assessed
-
Involvement of a Mitogen-activated Protein Kinase Signaling Pathway in the Regulation of Urokinase Promoter Activity by c-Ha-ras ↗Journal of Biological Chemistry · 1995 · PMID 7559439not yet assessed
-
Stimulation of urokinase expression by TNF-α requires the activation of binding sites for the AP-1 and PEA3 transcription factors ↗Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1995 · PMID 7626664not yet assessed
-
Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. ↗PubMed · 1995 · PMID 7653995not yet assessed
-
677 The clinical importance of keratin 18 in breast cancer ↗European Journal of Cancer · 1995not yet assessed
-
Keratin expression reveals mosaic differentiation in vaginal epithelium ↗American Journal of Obstetrics and Gynecology · 1993 · PMID 7505531not yet assessed
-
[Description of post-abortion sepsis with a fatal result in the noval "Seobe" by Miloś Crnjanski]. ↗PubMed · 1977 · PMID 616996not yet assessed
-
[The Paget's disease--a gerontological study (author's transl)]. ↗PubMed · 1976 · PMID 983152not yet assessed
-
[Giant fibroadenoma of the breast in young age]. ↗PubMed · 1973 · PMID 4743667not yet assessed
-
[Operated pulmonary metastasis]. ↗PubMed · 1972 · PMID 5069690not yet assessed
-
[Primary neoplasms of the trachea]. ↗PubMed · 1970 · PMID 4311331not yet assessed
-
CONTRIBUTION TO THE STUDY OF CALCIUM METABOLISM CLINICALLY USING CALCIUM- 47. PRELIMINARY NOTEOSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · 1962not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
Merged across profiles sharing this ORCID where present. See every “Lengyel E” paper on PubMed ↗